Who Owns SABSW?

SAB Biotherapeutics, Inc. Warrant — Institutional Ownership & 13F Holdings

$0.02

-0.00 (-5.59%)

Market Cap

$357K

Shares Outstanding

9,558,166

Institutional Holders

8

Total Inst. Value

$30K

% of Float Held

QoQ Holder Change

-4

Institutional data as of Q1 2025

New Positions

1

Closed Positions

3

Increased

1

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1LMR Partners LLP$19K539,588
2MORGAN STANLEY$3K146,439
3Yakira Capital Management, Inc.$2K78,733
4Tabor Asset Management, LPNew$2K78,733
5HB Wealth Management, LLC$2K60,000
6Walleye Trading LLC$82831,863
7WOLVERINE ASSET MANAGEMENT LLC$1614,620
8NewEdge Advisors, LLC$281,072

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
Tabor Asset Management, LPNew+79K$2K
HB Wealth Management, LLC+10K$2K

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold SABSW?

As of Q1 2025, 8 institutional investors report holding SABSW (SAB Biotherapeutics, Inc. Warrant) in their 13F filings.

Which hedge fund owns the most SABSW?

The largest institutional holder of SABSW is LMR Partners LLP with $19K in shares.

Are institutions buying or selling SABSW?

This quarter, 1 institutions opened new positions in SABSW and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.